Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Multiple Myeloma 6Melanoma 5Glioblastoma 5Lymphoma 4Breast Neoplasms 4Recurrence 3Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Leukemia 3Glioma 3Carcinoma, Ovarian Epithelial 3Rectal Neoplasms 2Prostatic Neoplasms 2Neuroblastoma 2Neoplasms 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 2Leukemia, Myelomonocytic, Chronic 2Hodgkin Disease 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Brain Neoplasms 2Advanced Malignant Solid Tumor 2Xanthomatosis, Cerebrotendinous 1Wilms Tumor 1Vaccinia 1

Interventions

sargramostim 1bryostatin 1 1Granulocyte-Macrophage Colony-Stimulating Factor 1Bryostatins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Hemoglobinuria, Paroxysmal × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00012376 2013-01-09

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer

National Cancer Institute (NCI)

Phase 1 Completed
35 enrolled
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, Blast Crisis, Hemoglobinuria, Paroxysmal, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡